Bloomberg Intelligence

The Fed, ETFs, Inflation, and Obesity Drugs (Podcast)

Share this episode
Anyone with this link can open it.
Share Link
Start at 0:00

This episode isn’t summarized yet

Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.

Show notes

Vince Cignarella, Macro Strategist for Bloomberg News, joins the show in studio to talk markets and inflation. Tim O’Brien, Senior Editor with Bloomberg Opinion, discusses the federal indictment and arraignment of Donald Trump. Joanna Gallegos, co-founder of BondBloxx, talks about ETF investment strategies and flows. Bloomberg cross asset reporter Katie Greifeld also joins. Jay Hatfield, CEO at Infrastructure Capital Management, joins the program to discuss his non-consensus view on inflation and outlook for rate hikes in the US. Michael Shah, Senior Industry Pharma Analyst with Bloomberg Intelligence, joins to discuss his research on the obesity drug battle. Gina Martin Adams, Chief US Equity Analyst for Bloomberg Intelligence, joins the program to talk about her note on the Russell 2000 and the market impact of a Fed pause. Geoff Phipps, Trading Strategist and Portfolio Manager at Picton Asset Management, joins to discuss markets and the Fed. Hosted by Paul Sweeney and Jess Menton.

See omnystudio.com/listener for privacy information.

Couldn't load the audio. A blocker may be stopping the show's tracking links. Open the file